View Older Stories View More Recent Stories
-
BioHarvest Sciences Issues Year End Shareholder Letter
-
BioHarvest Sciences receives $1.6 million grant from Israeli authority
-
BioHarvest Sciences Awarded $1.6 Million USD Grant from the Israeli Innovation Authority to Advance Second-Generation Botanical Synthesis Platform
-
BioHarvest Sciences launches VINIA blood flow hydration product
-
BioHarvest Sciences Announces Launch of VINIA Blood Flow Hydration Product
-
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
-
BioHarvest Sciences to Attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025
-
BioHarvest Sciences closes $19.9 million public offering
-
BioHarvest Sciences Announces Closing of $19.9 Million Upsized Public Offering of Common Stock and Exercise of Underwriter's Option to Purchase Additional Shares
-
BioHarvest Sciences prices $17.4 million public offering at $7 per share
-
BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
-
BioHarvest announces underwritten public offering of common stock
-
BioHarvest Announces Proposed Public Offering of Common Stock
-
BioHarvest Sciences to Host Third Quarter Earnings Call on November 13 at 4:30 p.m. Eastern Time
-
BioHarvest Sciences partners with Saffron Tech for compound production
-
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
-
BioHarvest Sciences raises $10.9 million, reduces debt by $3.8 million
-
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
-
BioHarvest Sciences produces plant-based exosomes at commercial scale
-
BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale
-
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
-
BioHarvest Sciences Reports Second Quarter 2025 Financial Results
-
BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time
-
BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
-
BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles
-
BioHarvest (BHST) secures new contract for plant-based fragrance development
-
BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
-
BioHarvest Sciences Reports First Quarter 2025 Financial Results
-
BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
-
Craig-Hallum Starts BioHarvest Sciences (BHST) at Buy
-
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
-
H.C. Wainwright Reiterates Buy Rating on BioHarvest Sciences (BHST)
-
BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
-
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
-
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
-
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
-
BioHarvest Sciences (BHST) Reports Sales of VINIA Now Exceed $50M
-
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
-
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
-
BioHarvest Sciences (BHST) Appoints Sharon Malka to its Board
-
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
-
BioHarvest Sciences (BHST) Issues Shareholder Letter and Provides Corporate Update
-
BioHarvest Issues Shareholder Letter and Provides Corporate Update
-
Maxim Group Starts BioHarvest Sciences (BHST) at Buy
-
H.C. Wainwright Reiterates Buy Rating on BioHarvest Sciences (BHST)
-
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
-
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
-
BioHarvest Launches VINIA SuperFood Functional Tea Line
-
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
-
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
